This Editas Medicine Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Analysts upgraded Microsoft, Graphic Packaging, Editas Medicine and Lakefront Biotherapeutics, with mixed price-target changes.
Stocks · News reference
Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields
Analyst ratings spotlight high-yield materials stocks Sonoco (4.46%), Olin (4.62%) and Graphic Packaging (4.69%), with mixed outlooks.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
JP Morgan Upgrades Graphic Packaging Holding to Overweight, Lowers Price Target to $11.5
JP Morgan analyst Detlef Winckelmann upgrades Graphic Packaging Holding (NYSE:GPK) from Neutral to Overweight and lowers the price target from $12.5 to $11.5.
B of A Securities Maintains Neutral on Graphic Packaging Holding, Lowers Price Target to $13
B of A Securities analyst George Staphos maintains Graphic Packaging Holding (NYSE:GPK) with a Neutral and lowers the price target from $14 to $13.
Citigroup Reinstates Neutral on Olin, Announces $19 Price Target
Citigroup analyst Patrick Cunningham reinstates Olin (NYSE:OLN) with a Neutral and announces $19 price target.
Olin, Huntsman Merger of Equals Clears U.S. Antitrust Hurdle
Olin Corporation and Huntsman Corporation have cleared the U.S. Hart-Scott-Rodino antitrust waiting period for their proposed all-stock merger of equals. The combined entity, OlinHuntsman Corporation, is expected to generate over $400 million in cost synergies and $125 million in cash tax benefits, with completion targeted for the first half of 2027.
Keybanc Initiates Coverage On Olin with Overweight Rating, Announces Price Target of $26
Keybanc analyst Salvator Tiano initiates coverage on Olin (NYSE:OLN) with a Overweight rating and announces Price Target of $26.